Geneesmiddelenbeleid

This procedure is a report on a committee debate regarding the Netherlands' pharmaceutical policy. It focuses on the strategic management of medicines, ensuring availability, and addressing the costs and regulation of healthcare products. This affects the healthcare sector, pharmaceutical companies, and patients by shaping how the government manages drug pricing, accessibility, and public health standards.